Munchkin Sold Fear to New Mothers and Called It a Cookie

A class action complaint filed in federal court says Munchkin, Inc. and its parent company Why Brands, Inc. built a premium product on a promise the science does not support: that eating their “Lactation Cookie Bites” will make a breastfeeding mother produce more milk. The complaint says the promise fails, and that the people who paid for it were mothers already afraid they could not feed their babies.

The Non-Financial Ledger

The complaint describes a harm that runs deeper than an overcharge. It targets a specific fear that many new mothers carry.

The complaint quotes the CDC finding that roughly 60% of mothers who stop breastfeeding do so earlier than they wanted, often because they worry their milk supply is insufficient. Research cited in the filing states that between 30% and 80% of lactating parents perceive their milk as insufficient to meet their infant’s needs. Into that anxiety, according to the complaint, Munchkin sold a product wrapped in phrases like “MORE MILK, PLEASE!” and “BRING ON THE MILK!”

Defendants’ own website, quoted in the filing, acknowledges that breastfeeding “can be a journey that’s both beautiful and harrowing at the same time” and that “[w]orries over milk supply” can “consume your mind in those early sleepless days.” The complaint’s core allegation is that Munchkin understood this fear intimately and then charged a premium to a mother hoping a cookie would fix it. The betrayal is that the reassurance was allegedly hollow.

Legal Receipts

The following passages are drawn directly from the complaint. They lay out the allegation in the plaintiffs’ own words.

“Defendants exploit one of parenthood’s most vulnerable moments – a mother’s concern about providing adequate nutrition for her infant.”

• This frames the entire case as targeted marketing aimed at a documented emotional vulnerability.
• It ties the alleged deception directly to infant nutrition, raising the stakes above a simple pricing dispute.

“The results were unequivocal: Defendants’ premium-priced Lactation Cookies did not increase milk production more than ordinary cookies. In fact, mothers consuming the Famous Amos cookies experienced on average greater increases in milk production than those consuming Defendants’ Lactation Cookies.”

• This cites a double-blind randomized controlled trial, the strongest form of consumer-product testing, as the evidentiary spine of the case.
• The claim that plain cookies outperformed the premium product turns the marketing on its head.

“Defendants have been manufacturing, distributing, and selling the Lactation Cookies for approximately ten years and knew or should have known, prior to distributing the Lactation Cookies into the consumer marketplace, that the Lactation Cookies fail to conform to Defendants’ Milk Production Representations.”

• This alleges a decade of sales, framing the conduct as sustained rather than a one-time error.
• The “knew or should have known” language is the legal foundation for the fraud and punitive damages claims.

“If consumers knew the truth, the price of Defendants’ Lactation Cookies would crater. Moreover, if consumers knew the truth, they would have paid significantly less for the Lactation Cookies.”

• This defines the alleged financial injury as a “price premium” attributable directly to the milk-supply claims.
• It sets up the damages theory: consumers paid more only because of the challenged representations.

Public Deception: What the Label Said vs. What the Study Found

The complaint alleges a direct gap between the marketing plastered across packaging and websites and the results of a controlled trial on the exact product.

• The label claimed the cookies were made “With Ingredients Traditionally Used To Support Breast Milk Supply,” while the 2023 study found no statistically significant milk-production benefit over plain cookies.
• The packaging branded Munchkin the “#1 Lactation Snack Brand,” while the complaint says the product performed no better than a standard grocery cookie.
• The label carried “Lactation Consultant Recommended,” which the complaint says leads consumers to believe the product was rigorously tested and scientifically established as effective.
• Side and back labels shouted “BRING ON THE MILK!” and “MORE MILK, PLEASE!” while, per the study, the control group made more milk.

Profit-Maximization at All Costs

The complaint alleges Munchkin kept selling the cookies despite both a controlled trial and years of consumer complaints, because the deception was profitable.

• The filing states Defendants continued distributing the product “in order to garner market share and capitalize on consumer demand for nursing support products and foods.”
• It alleges the premium price was “based on their deceptive promises,” meaning the extra margin depended on the milk-supply claims being believed.
• The complaint cites the study authors noting the cookies are high in calories and sugar and “may attenuate postpartum weight loss without offering any major nutritional benefit.”
• Consumer complaints on Amazon.com since at least 2018 allegedly put Defendants on notice that the product failed to work as advertised, yet sales continued.

How Capitalism Exploits Delay: Time as a Weapon

The complaint documents a long gap between when the evidence against the product existed and when accountability arrived.

• The complaint alleges roughly ten years of sales before this lawsuit, meaning years of consumers paying the premium while the product allegedly did nothing extra.
• Consumer complaints dating to at least 2018 allegedly gave Defendants early notice, yet the marketing continued.
• The definitive 2023 study existed roughly three years before the suit was filed in June 2026.

The Contractor Shield: Parent Company, Same Address

The complaint names both Munchkin, Inc. and its parent Why Brands, Inc. as defendants, alleging the parent directed the conduct rather than sitting at arm’s length.

• Why Brands, Inc. is named as the parent company of Munchkin, Inc., with both sharing a principal place of business in Van Nuys, California.
• The complaint alleges Why Brands “directs and controls its operations, including the manufacturing, advertising, labeling, sale, and distribution of the Lactation Cookies nationwide.”
• It alleges a shared Chief Brand Officer & Creative Director managing brand design across both entities, tying the marketing decisions to the parent.
• By naming the parent directly, plaintiffs seek to prevent liability from being confined to the subsidiary alone.

Societal Impact Mapping

Public Health

The complaint frames the product as intersecting directly with infant nutrition and maternal wellbeing.

• The product allegedly targets mothers worried about feeding their infants, a group the complaint says is under intense pressure to produce enough milk.
• The CDC data cited shows roughly 60% of mothers who stop breastfeeding do so earlier than desired, often over supply concerns the product claimed to address.
• The study authors, per the complaint, warned the high-calorie, high-sugar cookies “may attenuate postpartum weight loss without offering any major nutritional benefit.”
• The complaint alleges the product offered false reassurance during a critical window when accurate information matters most for infant feeding decisions.

Economic Inequality

The complaint centers on a premium price extracted through allegedly false claims.

• Plaintiffs allege they paid a “price premium” they would not have paid had they known the cookies were no more effective than cheaper alternatives.
• The comparison product, Famous Amos cookies, is described as “significantly less expensive” while allegedly performing as well or better.
• The complaint estimates tens of thousands of class members and aggregate claims exceeding $5,000,000, indicating widespread financial extraction.
• The burden fell on new parents, a group frequently managing tight budgets during a costly life stage.

Who Pays? Following the Cost

The complaint alleges the cost of the deception landed squarely on individual mothers who paid a premium for a promise the product did not keep.

• The financial injury originated with Defendants’ marketing and was absorbed by consumers as a per-purchase price premium tied to the milk-supply claims.
• The complaint alleges aggregate class claims exceeding $5,000,000, spread across an estimated tens of thousands of purchasers.
• Plaintiff Quintana bought the Oatmeal Chocolate Chip flavor at a California Target; Plaintiff Lopez bought Chocolate Salted Caramel at a Walmart; Plaintiffs Ether and Fassbinder bought through Amazon.com.
• Each purchaser, per the complaint, received a cookie functionally equivalent to a cheaper grocery cookie while paying for a specialized lactation product.

The “Cost of a Life” Metric

This Is the System Working as Intended

The complaint describes a market failure that only reaches a courtroom years after the harm began, and only through private litigation rather than regulatory action.

• Munchkin allegedly sold the product for roughly ten years and through years of consumer complaints before any legal challenge landed, per the complaint.
• A definitive controlled trial existed since 2023, yet the complaint alleges the marketing continued unchanged until plaintiffs’ counsel noted quiet label edits in early 2026.
• The complaint notes the wider context: it cites commentary that “seeing a business opportunity, a large industry has developed that targets women at this vulnerable time.”
• Accountability here depends on consumers organizing a class action, not on a government agency catching the claim before it reached shelves.

What a Legitimate Fix Looks Like

Editorial analysis: this case exposes how supplement-adjacent food products can carry health-adjacent claims without the testing consumers assume backs them. The following are our recommendations, not findings of the complaint.

Regulatory Track

• The FTC should require that any product claiming a physiological benefit like increased milk supply hold competent and reliable scientific substantiation before the claim reaches a label.
• The FDA should scrutinize “traditionally used to support” phrasing, which the complaint alleges functions as an efficacy claim while dodging efficacy standards.
• Retailers selling third-party lactation products should be pushed toward disclosure standards so an Amazon or Target listing cannot amplify unsupported health claims.

Legislative Track

• Legislatures should close the gap that lets a food product make quasi-medical claims aimed at postpartum mothers without the substantiation required of a health product.
• Statutory penalties should be scaled to total revenue from a deceptive product line, not treated as a routine cost of doing business over a decade of sales.
• State consumer-fraud statutes like California’s CLRA, New York’s GBL, and Illinois’s ICFA should be funded for proactive enforcement rather than relying on private plaintiffs.

Corporate Governance Track

• The board should require documented scientific substantiation on file before any efficacy claim is approved for packaging.
• The Chief Brand Officer function, which the complaint ties to both parent and subsidiary, should carry personal sign-off accountability for health-adjacent claims.
• An internal complaint-review process should trigger a claims audit when consumer reports of ineffectiveness reach a set threshold, rather than continuing sales through years of complaints.

What Now?

Direct your attention to the two named defendants, Munchkin, Inc. and Why Brands, Inc., both headquartered in Van Nuys, California, and to the agencies that should have caught this.

• Watchlist: the Federal Trade Commission, which polices deceptive advertising and health-benefit substantiation.
• Watchlist: the Food and Drug Administration, which oversees claims on food and supplement labeling.
• If you bought Munchkin Lactation Cookie Bites, keep your receipts and order histories; class members are identified through sales records.
• Connect with local parenting and breastfeeding-support groups and lactation consultants who can share evidence-based guidance instead of marketing.
• Support mutual-aid networks and milk-sharing communities that help new parents without charging a premium on their fear.